[3-(3,5-Dichloro-phenylcarbamoyl)cyclopentyl]carbamic acid tert-butyl ester

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: [3-(3,5-Dichloro-phenylcarbamoyl)cyclopentyl]carbamic acid tert-butyl ester
• 英文别名: [3-(3,5-Dichlorophenylcarbamoyl)cyclopentyl]carbamic acid tert-butyl ester；tert-butyl N-[3-[(3,5-dichlorophenyl)carbamoyl]cyclopentyl]carbamate
• 化学式: C₁₇H₂₂Cl₂N₂O₃
• 分子量: 373.279
• InChiKey: NBOMTVCLMLYDHC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  67.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  3-(叔丁氧基羰基)环戊烷羧酸 、 3,5-二氯苯胺 、 氯甲酸异丁酯 在 三乙胺 作用下， 以 正己烷 、 二氯甲烷 为溶剂， 生成 [3-(3,5-Dichloro-phenylcarbamoyl)cyclopentyl]carbamic acid tert-butyl ester
  参考文献：
  名称：

  Bisubstituted carbocyclic cyclophilin binding compounds and their use

  摘要：

  本发明涉及一种新型的非肽类小有机化合物，具有与环存肥蛋白（CyP）型免疫蛋白亲和力。在本发明的化合物中，至少有两个碳环或杂环基团通过直链或支链连接到一个中央的饱和、部分饱和或芳香性的5-6环碳环上。本发明还涉及包含所述化合物中的一个或多个的制药组合物，并且用于结合CyP型蛋白，抑制其肽基-脯氨酰异构酶活性，以及在各种医学疾病中进行研究、开发和治疗应用，例如神经系统疾病、脱发疾病、缺血性疾病和由病毒或原虫感染引起的疾病。

  公开号：

  US20020127605A1

文献信息

• BISUBSTITUTED CARBOCYCLIC CYCLOPHILIN BINDING COMPOUNDS AND THEIRUS
  申请人：GUILFORD PHARMACEUTICALS INC.

  公开号：EP1339668A2

  公开（公告）日：2003-09-03
• [EN] BISUBSTITUTED CARBOCYCLIC CYCLOPHILIN BINDING COMPOUNDS AND THEIRUS<br/>[FR] COMPOSES DE LIAISON DE CYCLOPHILINE CARBOCYCLIQUE BISUBSTITUEE ET LEUR UTILISATION
  申请人：GUILFORD PHARM INC

  公开号：WO2002044126A2

  公开（公告）日：2002-06-06

  The present invention relates to novel, non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilin proteins. In the compounds of this invention, at least two carbo-or heterocyclic groups are attached to a central saturated, partially saturated, or aromatic 5-6 membered carbocyclic ring by a combination of straight or branched linker chains. The invention further relates to pharmaceutical compositions comprising one or more of the said compounds, and to the uses of these compounds and compositions for binding CyP-type proteins, inhibiting their peptidyl-prolyl isomerase activity, and for research, development, and therapeutic applications in a variety of medical disorders, such as neurological disorders, hair loss disorders, ischemic disorders, and disorders caused by viral or protozoan infection.
• Bisubstituted carbocyclic cyclophilin binding compounds and their use
  申请人：——

  公开号：US20020127605A1

  公开（公告）日：2002-09-12

  The present invention relates to novel, non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilin proteins. In the compounds of this invention, at least two carbo- or heterocyclic groups are attached to a central saturated, partially saturated, or aromatic 5-6 membered carbocyclic ring by a combination of straight or branched linker chains. The invention further relates to pharmaceutical compositions comprising one or more of the said compounds, and to the uses of these compounds and compositions for binding CyP-type proteins, inhibiting their peptidyl-prolyl isomerase activity, and for research, development, and therapeutic applications in a variety of medical disorders, such as neurological disorders, hair loss disorders, ischemic disorders, and disorders caused by viral or protozoan infection.

  本发明涉及一种新型的非肽类小有机化合物，具有与环存肥蛋白（CyP）型免疫蛋白亲和力。在本发明的化合物中，至少有两个碳环或杂环基团通过直链或支链连接到一个中央的饱和、部分饱和或芳香性的5-6环碳环上。本发明还涉及包含所述化合物中的一个或多个的制药组合物，并且用于结合CyP型蛋白，抑制其肽基-脯氨酰异构酶活性，以及在各种医学疾病中进行研究、开发和治疗应用，例如神经系统疾病、脱发疾病、缺血性疾病和由病毒或原虫感染引起的疾病。